The treatment of hyperphosphataemia in CKD: calcium-based or calcium-free phosphate binders?

被引：34

作者：

Cozzolino, Mario ^{[1
]}

Mazzaferro, Sandro ^{[2
]}

Brandenburg, Vincent ^{[3
]}

机构：

[1] Univ Milan, Div Renal, S Paolo Hosp, Milan, Italy

[2] Univ Roma La Sapienza, Dept Clin Sci, Rome, Italy

[3] Rhein Westfal TH Aachen, Univ Hosp Aachen, Div Cardiol, Aachen, Germany

来源：

NEPHROLOGY DIALYSIS TRANSPLANTATION | 2011年 / 26卷 / 02期

关键词：

CKD; hyperphosphataemia; phosphate binders; CHRONIC KIDNEY-DISEASE; CORONARY-ARTERY CALCIFICATION; SEVELAMER HYDROCHLORIDE; FETUIN-A; VASCULAR CALCIFICATION; AORTIC CALCIFICATION; CROSSOVER DESIGN; SERUM PHOSPHATE; MORTALITY RISK; CARBONATE;

D O I：

10.1093/ndt/gfq691

中图分类号：

R3 [基础医学]; R4 [临床医学];

学科分类号：

100103 [病原生物学]; 100218 [急诊医学];

摘要：

引用

页码：402 / 407

页数：6

共 53 条

[1]

Association of Serum Phosphate with Vascular and Valvular Calcification in Moderate CKD [J].

Adeney, Kathryn L. ;

Siscovick, David S. ;

Ix, Joachim H. ;

Seliger, Stephen L. ;

Shlipak, Michael G. ;

Jenny, Nancy S. ;

Kestenbaum, Bryan R. .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 20 (02) :381-387

[2]

Age and gender are the strongest clinical correlates of prevalent coronary calcification (R1) [J].

Allison, MA ;

Wright, CM .

INTERNATIONAL JOURNAL OF CARDIOLOGY, 2005, 98 (02) :325-330

[3]

Phosphate Binder Impact on Bone Remodeling and Coronary Calcification - Results from the BRiC Study [J].

Barreto, Daniela Veit ;

Barreto, Fellype de Carvalho ;

de Carvalho, Aluizio Barbosa ;

Cuppari, Lilian ;

Draibe, Sergio Antonio ;

Dalboni, Maria Aparecida ;

Affonso Moyses, Rosa Maria ;

Neves, Katia Rodrigues ;

Jorgetti, Vanda ;

Miname, Marcio ;

Santos, Raul D. ;

Fernandes Canziani, Maria Eugenia .

NEPHRON CLINICAL PRACTICE, 2008, 110 (04) :C273-C283

[4]

Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients [J].

Block, G. A. ;

Raggi, P. ;

Bellasi, A. ;

Kooienga, L. ;

Spiegel, D. M. .

KIDNEY INTERNATIONAL, 2007, 71 (05) :438-441

[5]

Mineral metabolism, mortality, and morbidity in maintenance hemodialysis [J].

Block, GA ;

Klassen, PS ;

Lazarus, JM ;

Ofsthun, N ;

Lowrie, EG ;

Chertow, GM .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (08) :2208-2218

[6]

Sevelamer and the bone-vascular axis in chronic kidney disease: bone turnover, inflammation, and calcification regulation [J].

Brandenburg, Vincent M. ;

Jahnen-Dechent, Willi ;

Ketteler, Markus .

KIDNEY INTERNATIONAL, 2009, 76 :S26-S33

[7]

Contribution of Intestine, Bone, Kidney, and Dialysis to Extracellular Fluid Calcium Content [J].

Bushinsky, David A. .

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 5 :S12-S22

[8]

Poly[allylamine hydrochloride] (RenaGel): A noncalcemic phosphate binder for the treatment of hyperphosphatemia in chronic renal failure [J].

Chertow, GM ;

Burke, SK ;

Lazarus, JM ;

Stenzel, KH ;

Wombolt, D ;

Goldberg, D ;

Bonventre, JV ;

Slatopolsky, E .

AMERICAN JOURNAL OF KIDNEY DISEASES, 1997, 29 (01) :66-71

[9]

Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients [J].

Chertow, GM ;

Burke, SK ;

Raggi, P .

KIDNEY INTERNATIONAL, 2002, 62 (01) :245-252

[10]

Pill Burden, Adherence, Hyperphosphatemia, and Quality of Life in Maintenance Dialysis Patients [J].

Chiu, Yi-Wen ;

Teitelbaum, Isaac ;

Misra, Madhukar ;

de Leon, Essel Marie ;

Adzize, Tochi ;

Mehrotra, Rajnish .

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 4 (06) :1089-1096

← 1 2 3 4 5 6 →